Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Cascio

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Advances in Experimental Medicine and Biology|April 30, 2009
Agonists and partial antagonists acting on the leptin--leptin receptor interfaceLaszlo Otvos, Marco Cassone, Marianna Terrasi, et al.
Oncogene|August 20, 2004
Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promotersCatia Morelli, Cecilia Garofalo, Diego Sisci, et al.
The Journal of Clinical Investigation|September 23, 2024
Egfl6 promotes ovarian cancer progression by enhancing the immunosuppressive functions of tumor-associated myeloid cellsSarah Hamze Sinno, Joshua A Imperatore, Shoumei Bai, et al.
Cancer Immunology Research|December 14, 2019
Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon CancerMichael Kvorjak, Yasmine Ahmed, Michelle L Miller, et al.
Biochimica Et Biophysica Acta|June 17, 2008
Development of a pharmacologically improved peptide agonist of the leptin receptorLaszlo Otvos, Marianna Terrasi, Sandra Cascio, et al.
Breast Cancer Research and Treatment|January 30, 2008
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?Antonio Russo, Valentina Calò, Loredana Bruno, et al.
Journal of Cellular Physiology|June 21, 2005
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinomaAntonio Russo, Simona Corsale, Valentina Agnese, et al.
Science Advances|November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibitionSandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Breast Cancer Research and Treatment|January 16, 2007
BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analysesAntonio Russo, Valentina Calò, Valentina Agnese, et al.
Breast Cancer Research and Treatment|October 26, 2005
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancerValentina Calò, Valentina Agnese, Grazia Gargano, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Advances in Experimental Medicine and Biology|April 30, 2009
Agonists and partial antagonists acting on the leptin--leptin receptor interfaceLaszlo Otvos, Marco Cassone, Marianna Terrasi, et al.
Oncogene|August 20, 2004
Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promotersCatia Morelli, Cecilia Garofalo, Diego Sisci, et al.
The Journal of Clinical Investigation|September 23, 2024
Egfl6 promotes ovarian cancer progression by enhancing the immunosuppressive functions of tumor-associated myeloid cellsSarah Hamze Sinno, Joshua A Imperatore, Shoumei Bai, et al.
Cancer Immunology Research|December 14, 2019
Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon CancerMichael Kvorjak, Yasmine Ahmed, Michelle L Miller, et al.
Biochimica Et Biophysica Acta|June 17, 2008
Development of a pharmacologically improved peptide agonist of the leptin receptorLaszlo Otvos, Marianna Terrasi, Sandra Cascio, et al.
Breast Cancer Research and Treatment|January 30, 2008
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?Antonio Russo, Valentina Calò, Loredana Bruno, et al.
Journal of Cellular Physiology|June 21, 2005
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinomaAntonio Russo, Simona Corsale, Valentina Agnese, et al.
Science Advances|November 12, 2021
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibitionSandra Cascio, Chelsea Chandler, Linan Zhang, et al.
Breast Cancer Research and Treatment|January 16, 2007
BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily): a mutation analysesAntonio Russo, Valentina Calò, Valentina Agnese, et al.
Breast Cancer Research and Treatment|October 26, 2005
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancerValentina Calò, Valentina Agnese, Grazia Gargano, et al.
Pageof 4